Form SCHEDULE 13G/A Arcellx, Inc. Filed by: Paradigm Biocapital Advisors LP
http://archive.fast-edgar.com/20260814/AKB2O22C8Z2262ZZ27ZL2MZZDA6Q72R2Z28Q
Filed on: August 14, 2026
Form 13F-NT D. E. SHAW & CO, L.P. For: Jun 30
http://archive.fast-edgar.com/20260814/AAB2222C8Z2262ZZ27ZA2MZZM6ICH2S2Z28Q
Filed on: August 14, 2026
Form NT 10-Q Bravo Multinational Inc. For: Jun 30
http://archive.fast-edgar.com/20260814/AJ2UC22CZ22YI2Z2222B2CEZ3W69ZZI22282
Filed on: August 14, 2026
Form SCHEDULE 13G/A BRC Inc. Filed by: Alyeska Investment Group, L.P.
http://archive.fast-edgar.com/20260814/A922B62CZ22CDZK222232ZO2RIMHSZ22X282
Filed on: August 14, 2026
Form SCHEDULE 13G Cerebras Systems Inc. Filed by: Atreides Management, LP
http://archive.fast-edgar.com/20260814/AHZZK22CZ22EG2W2222N22Z2PVLNZZ289H82
Filed on: August 14, 2026
More SEC Filings
View Older Stories-
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: MONTANOVA CAPITAL, LLC
-
Form N-CEN Kurv ETF Trust For: May 31
-
Form N-PX Carlyle Group Inc. For: Jun 30
-
Form S-3 60 DEGREES PHARMACEUTICA
-
Form SCHEDULE 13G First Tracks Biotherapeu Filed by: TCG Crossover GP II, LLC
-
Form SCHEDULE 13G/A Abivax S.A. Filed by: TCG Crossover GP I, LLC
-
Form SCHEDULE 13G/A BANK OF THE JAMES FINANC Filed by: Fourthstone LLC
-
Form SCHEDULE 13G/A Faeth Therapeutics, Inc. Filed by: Caligan Partners LP
-
Form SCHEDULE 13G/A ASSEMBLY BIOSCIENCES, Filed by: Paradigm Biocapital Advisors LP
-
Form SCHEDULE 13G Organon & Co. Filed by: Pentwater Capital Management LP
-
Form 13F-HR Hound Partners, LLC For: Jun 30
-
Form SCHEDULE 13G/A MASIMO CORP Filed by: Pentwater Capital Management LP
-
Form SCHEDULE 13G SPS COMMERCE INC Filed by: DISCIPLINED GROWTH INVESTORS INC /MN
-
Form SCHEDULE 13G/A SKYX Platforms Corp. Filed by: Alyeska Investment Group, L.P.
-
Form 25-NSE Myseum.AI, Inc. Filed by: Nasdaq Stock Market LLC
-
Form SCHEDULE 13G/A InflaRx N.V. Filed by: MONTANOVA CAPITAL, LLC
-
Form SCHEDULE 13G TXNM ENERGY INC Filed by: Pentwater Capital Management LP
-
Form N-PX Opus Capital Group, LLC For: Jun 30
-
Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Pentwater Capital Management LP
-
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
-
Form 13F-NT Fortress Credit Opportun For: Jun 30
-
Form 10-Q BIOLARGO, INC. For: Jun 30
-
Form 13F-HR Ampersand Capital Group, For: Jun 30
-
Form 13F-NT Coatue Structured Co-Inv For: Jun 30
-
Form 13F-HR Greycroft LP For: Jun 30
-
Form 13F-NT Pershing Square Manageme For: Jun 30
-
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TCG Crossover GP II, LLC
-
Form SCHEDULE 13G/A Bleichroeder Acquisition Filed by: Alyeska Investment Group, L.P.
-
Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: MONTANOVA CAPITAL, LLC
-
Form SCHEDULE 13G/A BATTALION OIL CORP Filed by: Alyeska Investment Group, L.P.
-
Form 4 Arteris, Inc. For: Aug 12 Filed by: Hawkins Nicholas B.
-
Form 8-K OPKO HEALTH, INC. For: Aug 13
-
Form 8-K TUTOR PERINI CORP For: Aug 11
-
Form 13F-NT DME Advisors, LP For: Jun 30
-
Form 13F-NT Fortress Credit Opportun For: Jun 30
-
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P
-
Form 13F-NT Greenlight Masters, LLC For: Jun 30
-
Form 13F-HR Foxhaven Asset Managemen For: Jun 30
-
Form 4 INTEL CORP For: Aug 11 Filed by: TAN LIP BU
-
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: Paradigm Biocapital Advisors LP
-
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 13F-HR INFINITUM ASSET MANAGEME For: Jun 30
-
Form 13F-HR Mutual Advisors, LLC For: Jun 30
-
Form 13F-HR PERSHING SQUARE INC. For: Jun 30
-
Form 13F-NT FINCO I LLC For: Jun 30
-
Form SCHEDULE 13G/A SunPower Inc. Filed by: Alyeska Investment Group, L.P.
-
Form 10-Q Banzai International, For: Jun 30
-
Form 13F-HR D. E. Shaw & Co., Inc. For: Jun 30
-
Form 13F-NT Coatue Strategic Maple For: Jun 30
